Synageva BioPharma Corp. , a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced its presentation at the upcoming Leerink Swann Global Healthcare Conference 2013.
http://www.businesswire.com/news/topix/20130206006554/en
http://www.businesswire.com/news/topix/20130206006554/en
No comments:
Post a Comment